Pancreatic Cancer Research

ResearcherUniversity of MinnesotaActive in the last 2 years

Julia Davydova

Matched on ORCID iD 0000-0001-5766-5722; OpenAlex author ID A5048788127; NIH RePORTER profile ID 8916123. Sources: OpenAlex.

Their work

Papers
7 (first author 2, last author 3)
Trials
0
Grants
3
Labs led
1
Collaborators
11
Papers, trials and grants by year

2012: 2 papers · 2013: 1 paper · 2014: none · 2015: 1 paper · 2016: 1 paper · 2017: none · 2018: 1 paper, 1 grant · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper, 1 grant · 2024: none · 2025: none · 2026: 1 grant

Papers 7

  1. Interferon-expressing oncolytic adenovirus + chemoradiation inhibited pancreatic cancer growth in a hamster model. Co-author DOI 10.1111/cas.15903↗
  2. Combination of interferon-expressing oncolytic adenovirus with chemotherapy and radiation is highly synergistic in hamster model of pancreatic cancer. Last author DOI 10.18632/oncotarget.24710↗
  3. Oncolytic Virotherapy Increases the Detection of Microscopic Metastatic Disease at Time of Staging Laparoscopy for Pancreatic Adenocarcinoma. First author DOI 10.1016/j.ebiom.2016.05.019↗
  4. Oncolytic adenovirus expressing interferon alpha in a syngeneic Syrian hamster model for the treatment of pancreatic cancer. Last author DOI 10.1016/j.surg.2015.01.006↗
  5. Intravenous genetic mesothelin vaccine based on human adenovirus 40 inhibits growth and metastasis of pancreatic cancer. Co-author DOI 10.1002/ijc.27983↗
  6. Generation of a novel, cyclooxygenase-2-targeted, interferon-expressing, conditionally replicative adenovirus for pancreatic cancer therapy. Last author DOI 10.1016/j.amjsurg.2012.02.016↗
  7. Delivery of interferon alpha using a novel Cox2-controlled adenovirus for pancreatic cancer therapy. First author DOI 10.1016/j.surg.2012.02.017↗

Grants 3

  1. Advancing Systematic Delivery of Oncolytic Adenovirus for Pancreatic Cancer R01CA276179↗
  2. Combination therapy with IFN expressing oncolytic adenovirus for pancreatic cancer R01CA228760↗
  3. Novel Theranostics for Pancreatic Cancer R01CA174861↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Masato Yamamoto · 6 shared papers, 1 shared grant, 2012–2023 · strength 1.23
  2. Christopher James LaRocca · 3 shared papers, 2015–2018 · strength 0.27
  3. Kazuho Inoko · 1 shared paper, 2023 · strength 0.19
  4. Shuhei Shinoda · 1 shared paper, 2023 · strength 0.19
  5. Mizuho Sato‐Dahlman · 1 shared paper, 2023 · strength 0.19
  6. Nikita Sharma · 1 shared paper, 2023 · strength 0.19
  7. Selwyn Maurice Vickers · 4 shared papers, 2012–2015 · strength 0.17
  8. Leonard Armstrong · 3 shared papers, 2012–2015 · strength 0.12
  9. Amanda O. Salzwedel · 1 shared paper, 2018 · strength 0.10
  10. Satoshi Yamasaki · 1 shared paper, 2013 · strength 0.05
  11. Amanda Kathleen Arrington · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.